In advanced multiple myeloma (MM), malignant cells have a high mitotic index [9] and chromosomal instability [10], suggesting that PLK inhibitors may be an attractive therapeutic option for this presently incurable disease. Here, PLK1 is linked to Miyoshi myopathy.